Facilitated By

San Antonio Medical Foundation

EFFECT OF COMBINED INCRETIN-BASED THERAPY PLUS CANAGLIFLOZIN ON GLYCEMIC CONTROL AND THE COMPENSATORY RISE IN HEPATIC GLUCOSE PRODUCTION IN TYPE 2 DIABETIC PATIENTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
DeFronzo,Ralph A
Funded by
JANSSEN SCIENTIFIC AFFAIRS LLC
Research Start Date
Status
Active
Clinical Care
Drug Discovery
Diabetes and Obesity